Skip to content
★ Sign in to follow
JJ

John J. Mccabe

Adicet Bio, Inc.Sesen Bio, Inc.Interleukin Genetics Inc
Total declarations
6
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€8,156

Latest filing published 06 Dec 2019 for Adicet Bio, Inc..

Filing timeline

BuySale
John J. Mccabe

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

John J. Mccabe: trading record in brief

This profile gathers the share dealings of John J. Mccabe across 3 companies, led by Sesen Bio, Inc., Adicet Bio, Inc. and Interleukin Genetics Inc. The record holds 6 filings, for trades running from 7 February 2006 to 6 December 2019.

Sales make up the whole of the open-market record (3 sales, €8,156). Besides market trades, the filings include 3 share grants.

The latest filing, published on 6 December 2019, reports a share grant in Adicet Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to John J. Mccabe

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ◆
    Vice President, FinanceExecutivesAdicet Bio, Inc.
    0SEC
    12,867 shares0Common StockSEC:0000899243-19-028706:0
  • ▼
    Chief Financial OfficerExecutivesSesen Bio, Inc.
    2,938 USD22SEC
    1,399 shares@ US$2.1034.0% of flowCommon StockSEC:0001485003-17-000004:0
  • ▼
    Chief Financial OfficerExecutivesSesen Bio, Inc.
    5,616 USD25SEC
    1,170 shares@ US$4.8061.6% of flowCommon StockSEC:0001485003-16-000150:0
  • ▼
    Senior Vice President, FinanceExecutivesSesen Bio, Inc.
    405 USD11SEC
    1,501 shares@ US$0.274.4% of flowCommon StockSEC:0001485003-16-000044:0
  • ◆
    Senior Vice President, FinanceExecutivesSesen Bio, Inc.
    0SEC
    10,000 shares0Common StockSEC:0001205535-15-000005:0
  • ◆
    Chief Accounting OfficerExecutivesInterleukin Genetics Inc
    52,000 USD0SEC
    8,000 shares@ US$6.50Common StockSEC:0001179110-06-003102:0

6 of 6 declarations